Literature DB >> 12034322

Detection of rare K-ras codon 12 mutations using allele-specific competitive blocker PCR.

Page B McKinzie1, Barbara L Parsons.   

Abstract

Allele-specific competitive blocker PCR (ACB-PCR) is a sensitive allele-specific amplification method in which preferential amplification of the mutant allele occurs by using a primer that has more mismatches to the wild-type allele than to the mutant allele (mutant-specific primer, MSP). Additionally, a non-extendable primer with more mismatches to the mutant allele than to the wild-type allele (blocker primer, BP) competes with the MSP for binding to the wild-type allele, thereby reducing background amplification from the wild-type allele. ACB-PCR primer design is largely dependent upon the basepair substitution being measured, making it unclear if this method is broadly applicable. In an earlier study, an H-ras codon 61 CAA-->AAA mutation had been detected by ACB-PCR at a sensitivity of 10(-5). In this study, ACB-PCR was applied to two human K-ras codon 12 mutations: GGT-->GTT and GGT-->GAT. The method was optimized by systematically altering the concentrations of Perfect Match PCR Enhancer, MSP, BP, and dNTPs. For each mutation, mutant fractions as low as 10(-5) were detected, indicating that this assay can be used on a variety of base substitution mutations. In addition, the results suggest that the 3'-terminal mismatches between the MSP and wild-type allele may be used to predict the ACB-PCR conditions that will be appropriate for the detection of other base substitution mutations. The range of concentrations for each of these components is narrow, making this method relatively easy to apply to additional mutational targets.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12034322     DOI: 10.1016/s1383-5718(02)00077-3

Source DB:  PubMed          Journal:  Mutat Res        ISSN: 0027-5107            Impact factor:   2.433


  9 in total

1.  SNP discovery in pooled samples with mismatch repair detection.

Authors:  Hossein Fakhrai-Rad; Jianbiao Zheng; Thomas D Willis; Kee Wong; Kent Suyenaga; Martin Moorhead; Jim Eberle; Yvonne R Thorstenson; Ted Jones; Ronald W Davis; Eugeni Namsaraev; Malek Faham
Journal:  Genome Res       Date:  2004-07       Impact factor: 9.043

2.  Allele-specific polymerase chain reaction for the imatinib-resistant KIT D816V and D816F mutations in mastocytosis and acute myelogenous leukemia.

Authors:  Christopher L Corless; Patina Harrell; Mario Lacouture; Troy Bainbridge; Claudia Le; Ken Gatter; Clifton White; Scott Granter; Michael C Heinrich
Journal:  J Mol Diagn       Date:  2006-11       Impact factor: 5.568

3.  A vertically stacked, polymer, microfluidic point mutation analyzer: rapid high accuracy detection of low-abundance K-ras mutations.

Authors:  Kyudong Han; Tae Yoon Lee; Dimitris E Nikitopoulos; Steven A Soper; Michael C Murphy
Journal:  Anal Biochem       Date:  2011-06-30       Impact factor: 3.365

4.  Mutation analysis of carbamoyl phosphate synthetase: does the structurally conserved glutamine amidotransferase triad act as a functional dyad?

Authors:  Emily J Hart; Susan G Powers-Lee
Journal:  Protein Sci       Date:  2008-05-05       Impact factor: 6.725

5.  Dilute-'N'-Go dideoxy sequencing of all DNA strands generated in multiplex LATE-PCR assays.

Authors:  Yanwei Jia; Adam Osborne; John E Rice; Lawrence J Wangh
Journal:  Nucleic Acids Res       Date:  2010-02-26       Impact factor: 16.971

6.  Novel assay of competitively differentiated polymerase chain reaction for screening point mutation of hepatitis B virus.

Authors:  Xiao-Mou Peng; Xue-Juan Chen; Jian-Guo Li; Lin Gu; Yang-Su Huang; Zhi-Liang Gao
Journal:  World J Gastroenterol       Date:  2003-08       Impact factor: 5.742

7.  High resolution melting analysis for the rapid and sensitive detection of mutations in clinical samples: KRAS codon 12 and 13 mutations in non-small cell lung cancer.

Authors:  Michael Krypuy; Genni M Newnham; David M Thomas; Matthew Conron; Alexander Dobrovic
Journal:  BMC Cancer       Date:  2006-12-21       Impact factor: 4.430

8.  Extendable blocking probe in reverse transcription for analysis of RNA variants with superior selectivity.

Authors:  Tho H Ho; Kien X Dang; Susanna Lintula; Kristina Hotakainen; Lin Feng; Vesa M Olkkonen; Emmy W Verschuren; Tuomas Tenkanen; Caj Haglund; Kaija-Leena Kolho; Ulf-Hakan Stenman; Jakob Stenman
Journal:  Nucleic Acids Res       Date:  2014-11-05       Impact factor: 16.971

9.  Fast simultaneous detection of K-RAS mutations in colorectal cancer.

Authors:  Ya-Sian Chang; Kun-Tu Yeh; Tien-Jye Chang; Connie Chai; Hsiu-Chin Lu; Nicholas C Hsu; Jan-Gowth Chang
Journal:  BMC Cancer       Date:  2009-06-11       Impact factor: 4.430

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.